Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study-Reference-Cited by-同舟云学术

Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study

Published:2018-04-17 Issue:2 Volume:139 Page:373-381
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Hempel Johann-Martin^ORCID,Brendle Cornelia,Bender Benjamin,Bier Georg,Skardelly Marco,Gepfner-Tuma Irina,Eckert Franziska,Ernemann Ulrike,Schittenhelm Jens

Funder

Else-Übelmesser Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-018-2872-y/fulltext.html

Reference41 articles.

1. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1

2. Scott JN, Brasher PMA, Sevick RJ et al (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59(6):947–949

3. Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34(6):463–469

4. Reuss DE, Kratz A, Sahm F et al (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130(3):407–417. https://doi.org/10.1007/s00401-015-1454-8

5. Reuss DE, Mamatjan Y, Schrimpf D et al (2015) IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol 129(6):867–873. https://doi.org/10.1007/s00401-015-1438-8

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients;BMC Cancer;2024-07-09

2. Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification;Journal of Neuro-Oncology;2024-06-24

3. Prognostic significance of contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype in adults;2024-05-21

4. Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes;Biomedicines;2024-04-18

5. Detection and Localization of Glioma and Meningioma Tumors in Brain MR Images using Deep Learning;Sakarya University Journal of Science;2023-06-30